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The synthesis of Fe(III) complexes with ligands N'-(4-Chlorobenzoyl)isonicotinohydrazide can be synthesized 
through mixing metal and ligand dissolved in ethanol by reflux at ± 75
o
C for 5 hours. The instruments for the 
characterization of the complex were used UV-Visible and Infrared Spectrophotometry. The aims of the study 
are: to determine the synthesis method, characterize of the complex, and to study the interaction of the complex 
with target receptors. The weight of the synthesized compound was obtained by 38.1 mg. The purity of the 
complex has been tested using the determination of melting point and got a melting point range was 196-198
o
C. 
The maximum wavelength of Fe(III)N'-(4-Chlorobenzoyl)isonicotinohydrazid) complex was  261.0 nm and 
provide absorption of Fe-O vibrations at wavenumbers 530.42 cm
-1
. The docking process was done using 
AutodockTools-1.5.6 software which shows that the Fe(III)N'-(4-Chlorobenzoyl) isonicotinohydrazide complex 
can interact with Enoyl-Acyl Carrier Protein Reductase from Mycobacterium Tuberculosis and it has better  
interaction than isoniazid or N'-(4-Chlorobenzoyl)isonicotinohydrazide compound with the acquisition of free 
energy binding (ΔG) -9.80 kcal/mol and inhibition constant (Ki ) 0.06529 μM.  
 






Recently, tuberculosis (TB) is still one 
of the world's public health problems that 
cause high morbidity and mortality. TB is a 
contagious infectious disease caused by the 
Mycobacterium tuberculosis (Kemenkes RI, 
2016). Based on the World Health 
Organization (WHO), Indonesia is ranked 3
rd
 
with the highest number of sufferers in the 
world after India and China (WHO, 2018). 
One of the most commonly used tuberculosis 
drugs is isoniazid. Isoniazid must be activated 
by KatG, a bacterial catalase-peroxidase 
enzyme in Mycobacterium tuberculosis. KatG 
catalyzes the formation of the isonicotinic acyl 
radical, which spontaneously couples 
with NADH to form the nicotinoyl-NAD 
adduct. This complex binds tightly to 
the enoyl-acyl carrier protein reductase InhA, 
thereby blocking the natural enoyl-AcpM 
substrate and the action of fatty acid synthase. 
This process inhibits the synthesis of mycolic 
acids, which are required components of 
the mycobacterial cell wall. Mycolic acid 
emptiness causes the structure of the cell wall 
to become weak and then broken so that 
mycobacteria die (Siswandono, 2016; Suarez 
et al., 2009; Timmins et al., 2004; Singh et al., 
2008).  
From the previous research that the N'-
(4-Chlorobenzoyl) isonicotinohydrazide has a 
free energy binding (-6.644 kcal/mol) and 
inhibition constant (19.15 µM) better than 
isoniazid (-4.64 kcal/mol; 398.64 µM) 
(Ruswanto et al., 2019). In another research, 
we have synthesis and in vitro test, some of the 
isonicotinohydrazide derivatives and they had 
been antibacterial activity and antituberculosis 





(Mardianingrum et al., 2019). From another 
research, the compound N'-(4-Chlorobenzoyl) 
isonicotinohydrazide has anti-bacterial 
activity, with a MIC (Minimum Inhibitory 
Concentration) value of 6.25 ppm in 
Mycobacterium tuberculosis (Ruswanto et al., 
2019). In comparison that the MIC for 
isoniazid (0.1 g/mL), rifampicin (0.5 g/mL) 
and ethambutol (4.0 g/mL) (Suo et al., 1988). 
In the study conducted by 
Mallikarjuna (2018) stated that the complex 
compound 2- (1H-indol-3-yldiazenyl)-4,5,6,7-
tetrahydro-1,3-benzothiazole synthesized 
showed potential antimicrobial activity against 
the pathogen tested. Its antimycobacterial 
activity showed higher than the free ligand. 
The complex of 3-aminoquinoxaline-
2-carbonitrile N1, N4-dioxide with Fe (III) 
metal showed good results because this 
complex showed bacteriostatic or bactericidal 
activity in vitro in Mycobacterium tuberculosis 
as the causative agent of tuberculosis, the 
results of this synthesis show a higher 
inhibitory effect than therapeutic therapy drugs 
(Tarallo et al., 2010). The isoniazid complex 
with several metals shows that they can inhibit 
mycobacterial growth better than its free 
ligand (Ali et al., 2017). 
Based on the above background, the 
development of antituberculosis drugs was 
performed by modifying the isoniazid 
derivative, namely the synthesis of the          
N'-(4-Chlorobenzoyl) isonicotinohydrazide 
with Fe (III) metal (Sousa et al., 2011). 
 
2. MATERIALS AND METHODS  
Instruments 
The instruments used in this research 
were Melting point apparatus, UV-Vis 
spectrophotometer Genesys 10S, Perkin Elmer 
Spectrum 100 FT-IR Spectrometer. Hardware 
and software equipment. The device used is a 
Samsung Laptop with Intel (R) Celeron (R) 
CPU 847 @ 1.10GHz RAM 2.00 GB 64-bit 
RAM, Marvin Sketch 5.2, AutodockTools-




In this research, we used N'-(4-Chloro-
benzoyl)isonicotinohydrazide, ethanol p.a, 
FeCl3.6H2O p.a, hydrochloric acid p.a, 
aquadest, DMSO (Dimethyl sulfoxide), free 
ligand structure, ligand structure N'-(4-
Chlorobenzoyl) isonicotinohydrazide, the 
structure of the ligand complex Fe (III) (N'-(4-
Chlorobenzoyl)isonicotinohydrazide, and 
Enoyl-Acyl Carrier Protein Reductase enzyme 
with PDB code 2X23. 
 
Synthesis of Fe (III) N'-(4-Chlorobenzoyl) 
isonicotinohydrazide Complex  
The N'-(4-chlorobenzoyl) isonicotino-
hydrazide (30 mg; 0.1094 mmol) was 
dissolved in ethanol (10 mL; solution A). The 
FeCl3.6H2O metal (14.61 mg; 0.0540 mmol) 
which has been dissolved in ethanol (20 mL; 
solution B), and then it was dripped slowly 
into solution A. The dropping process was 
performed constantly and at low heating. 
Furthermore, the reflux was performed for 5 
hours at ± 75 
o
C and stirred using a magnetic 
stirrer then the reflux results were filtered and 
the residue obtained was dried (Zheng et al., 
2008; Ruswanto et al., 2018; Ruswanto et al., 
2019). 
 
The Purity Test of The Complex  
The purity test of the synthesis results 
was carried out by analysis of the 
determination of the melting point by using a 
modified Melting Point Apparatus. Direct 
observation of the melting point is done when 
the compound starts to melt until it melts 
completely (Ruswanto et al., 2019). 
 
UV-Vis Spectrophotometry 
Samples and standards were dissolved 
in DMSO with concentrations of 10
-2
 M to 10
-4
 
M, and then the electronic spectrum was 
measured with UV-Vis spectrophotometry. 
Electronic spectrum measurements were 
performed at 200-800 nm. Uptake was 
observed at absorbance which corresponds to 
maximum wavelengths using UV-Vis 
(Mardianingrum et al., 2020).  
 
Infrared Spectrophotometry 
The KBr powder was weighed as 
much as 15 mg, while for samples of about 5-
10% of KBr, then crushed on a mortar until 
smooth and homogeneous, then put 
sufficiently into a pelletizer that has been 
cleaned and dried with chloroform. After 
finishing, the pelletizer is opened slowly, and 
the pellet that has been formed must be 
transparent. Each sample pellet that has been 
prepared is ready to be measured in the region 
of wave number 4400-400 cm-1 (Ruswanto et 
al., 2018). 





The docking process was performed 
using AutodockTools-1.5.6 software between 
the Fe(III) N'-(4-Chlorobenzoyl) isonicotino-
hydrazide ligand with the Enoyl-Acyl Carrier 
Protein Reductase enzyme in Mycobacterium 
Tuberculosis (PDB code 2X23) through 
several stages. 
 
Ligand and Receptors Preparation 
Free ligand and complex structures 
were drawn in a 2-dimensional form. Then, 
they were done geometry optimization using 
Marvin Sketch 5.2 software. The ligand was 
initially protonated at pH 7.4. The protonation 
was performed to adjust the pH condition of 
blood in the human body. Then, the 
conformation was performed to get the most 
stable molecular position to interact with the 
active site of the enzyme. The file was saved in 
.mrv and .pdb format for the docking process 
(Endah et al., 2018). The enzyme preparation 
was performed using the AutodockTools-1.5.6 
software to remove water molecules and the 
addition of hydrogen atoms. 
 
The Validation of Docking Method  
Method validation was done by re-
docking native ligand (TCU) which was in 
2X23. The parameter for method validation 
was the root mean square deviation (RMSD) 
value. The docking method was declared valid 
if the RMSD value ≤ 2. But if the RMSD value 
≥ 2, it means the method used cannot be 
trusted (Agistia et al., 2013; Endah et al., 
2018). 
 
Analysis of Enzyme Target 
Analysis of the enzyme target was 
performed by looking at the 2X23 GDP protein 
profile on the website 
https://www.ebi.ac.uk/pdbsum/. The results of 
the enzyme target analysis were used to see 
that the enzyme was good by seeing the 
Ramachandran plot (Ruswanto et al., 2018). 
 
Docking Ligands Against Target Receptors 
The docking process is done using 
AutodockTools-1.5.6 software. The ligand 
docking process is done using parameters used 
in the docking validation process. From the 
docking process can be obtained binding 
affinity (ΔG) of each docking ligand. To see 
the interaction between the ligand and the 
active site of the receptor from the docking 
results, the software Discovery Studio version 
16.1 (Pal et al., 2019). 
  
Visualization of Docking Results 
Visualization of docking results was 
performed using Discovery Studio version 
16.1 software by seeing the interaction 
between ligands and amino acid residues on 
the enzyme target in 2D and 3D forms. 
 
Prediction of ADME and Toxicity 
To find out about the ADME 
parameters and toxicity done through the 
PreADMET program, which was accessed at 
https://preadmet.bmdrc.org/. The first, the 
structure was converted in the molfile format 
(*.mol) and the PreADMET program will 
automatically calculate the predicted 
absorption for Caco-2 cells, HIA (Human 
Intestinal Absorption), plasma protein binding 
(PPB) and its toxicity parameters through the 
amest test (Ruswanto et al., 2017). 
 
3. RESULTS AND DISCUSSION 
Synthesis of the Fe(III)N'-(4-Chlorobenzoyl) 
isonicotinohydrazide Complex 
Synthesis of the Fe (III) N '- (4-
Chlorobenzoyl) isonicotinohydrazide complex 
has occurred through the reaction of coordinate 
covalent bonds between the metal ion Fe (III) 
and the N'-(4-Chloro benzoyl)isonicotino-
hydrazide compound. The solvent used in the 
process of synthesis of complex compounds 
was ethanol. Ethanol was chosen because the 
compound N '- (4-Chloro benzoyl)isonicotino-
hydrazide has been good solubility in ethanol. 
The Complex formation was 
performed by the reflux method for 5 hours at 
±75 
o
C while stirring using a magnetic stirrer. 
The N'-(4-Chlorobenzoyl)isonicotinohydrazide 
as much as 30 mg (0.1094 mmol) and 
FeCl3.6H2O as much as 14.61 mg (0.054 
mmol). The method used in the reaction was 
the reflux method, where this method would be 
able to maintain stability so that complex 
synthesis reactions were performed even in hot 
conditions so that the reactant moles and 
products were maintained (Ningtyas, 2016). 
The use of ±75 
o
C temperature and stirring 
using a magnetic stirrer which aimed to 
accelerate and optimize the synthesis reaction 
process. Increasing the temperature and 
stirring would increase the kinetic energy to 
collide with each other, so the chances of a 





reaction would be even greater and faster 
(Dharmayanti, 2015; Goeswin, 2012). 
After the reflux was finished, the 
reflux results were evaporated in an electric 
water bath at 60 
o
C so that the remaining 
solvent resulting from the synthesis 
evaporates. After that, it was allowed to stand 
until the dry residue was weighed, and a 
complex compound of 38.1 mg was obtained. 
The synthesis results obtained the brown 
powder, odorless, and soluble in ethanol. 
 
Purity Test 
The purity test aimed to ensure that the 
compound produced was a new compound. 
Compounds were said to be pure when the 
melting distance was ≤2 
o
C (Ritmaleni, 2006). 
The melting distance data were listed in Table 
1. The difference in the melting distance 
between the results of the synthesis with the 
comparison shows that the new compound has 
been successfully formed. 
 
Table 1. The melting distance results 
 
















Characterization and Identification of The 
Complex 
Characterization and identification of 
the complex were performed using the UV-Vis 
Spectrophotometry and Infrared 
Spectrophotometry methods. 
The first identification and 
characterization were using UV-Vis 
spectrophotometry which aims to determine 
the existence of a shift in the maximum 
wavelength of the synthesized compound and 
be compared with the maximum wavelength of 
the comparison compound. Based on the 
results of wavelength measurements using UV-
Vis spectrophotometry, the maximum 
wavelengths obtained were shown in Table 2. 
Based on Table 2 showed that there 
was a difference in the maximum wavelength 
between the ligand with the complex 
compound Fe(III) N'-(4-Chlorobenzoyl) 
isonicotinohydrazide, where the maximum 
wavelengths were respectively 272.0 nm and 
261.0 nm. The difference in maximum 
wavelength indicated that the complex 
compound Fe (III) N'-(4-Chlorobenzoyl) 
isonicotinohydrazide has been formed. 
The maximum wavelength of the 
complex compound Fe (III) N'-(4-
Chlorobenzoyl)isonicotinohydrazide under- 
goes a shift in the absorption band toward 
shorter wavelengths or the presence of blue 
shift or hypochromic was detected. The 
maximum wavelength shift was influenced by 
the transfer of charge from the metal to the 
ligand and was also influenced by the polarity 
of the solvent (Ningtyas, 2016; Hastuti, 2017). 
The next step is to determine the 
electronic spectrum to find out the electronic 
transition that occurs in the synthesis complex 
and the amount of transition energy needed for 
complex division. The magnitude of the 
maximum wavelength shift (λmax), 
absorbance (A) of molar absorptivity (ε) and 
the value of 10 Dq of the complex compound 
Fe(III)N'-(4-Chlorobenzoy) 
isonicotinohydrazide can be seen in Table 3. 
Based on Table 3, it could be seen that 
the electronic spectrum of the compound Fe 
(III) N'-(4-Chlorobenzoyl) isonicotino 
hydrazide showed only one absorption band at 
a wavelength of 261.0 nm (38314.18 cm
-1
) and 





. This allows a charge 
transfer transition to occur (Borde, 2015). 
While the value of 10 Dq in the Fe (III) N'-(4-
Chlorobenzoyl) isonicotinohydrazide complex 
was 458.411 KJ.mol
-1
. This 10 Dq value was 
the amount of transition energy needed for 
complex division (Ruswanto et al., 2018). 
The next characterization was using 
infrared spectrophotometry which aimed to 
determine the functional groups and types of 
bonds found in the complex compound Fe (III) 
N'-(4-Chlorobenzoyl) isonicotinohydrazide so 
that the bond structure of the complex 
compound could be predicted. FTIR 




spectra of complex compounds, especially in 
the fingerprint area that characterizes a 
complex so that it could be predicted whether 
complex compounds have been formed or not 
(Dharmayanti, 2015). The infrared spectrum 
data  were  shown in Figures 1 and 2, and 
Table  4. 
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Tabel 2. The UV-Vis spectrums  
 





















Mean 1.398 261.0 
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330.15 261.0 38314.18 1.398 1282.57 458.411 
 
 
       





Figure 2. The infra red spectrum of the complex  





Table 4. The IR spectrum value of N’-(4-Chlorobenzoyl)isonicotinohydrazidedan and Fe(III)N’-(4-Chloro-
benzoyl)isonicotinohydrazide Complex 
 










1. N-H 3278.99 3431.36 











5. C-Cl 745.35 746.45 
7. Fe-O - 530.42 
 
 
In infrared spectra, functional groups 
were identified such as a stretched NH group 
in the region of wave number 3431.36 cm
-1
, 
where NH groups could cause hydrogen bonds 
to form so that the wavenumber and absorption 
it produces is high (Coates, 2000; Ruswanto et 
al., 2018 ). Theoretically, the vibration 
absorption of C=O could occur in the region of 
wave numbers 1800-1650 cm
-1
 (Widata, 2018). 
Absorption of C=O complex compounds was 
in the region of 1651.07 cm
-1
, this wave 
number was slightly lower because of the 
mesomeric effect (delocalization of electrons π 
on bonds) so that the vibrational frequency 
decreases (Ruswanto et al., 2018). The 
aromatic group was strengthened by the 





 which is the stretching vibration 
of the C=C bond. This was consistent with the 
literature, which states that the vibration 
absorption of C=C was in the area of 1600-
1475 cm
-1
 (Kusyanto, 2017; Sastrohamidjojo, 
2001). Vibration uptake in the region of 
1276.88 cm
-1
 was stretching vibration 
absorption from C-N bonds, and this was in 
accordance with the literature which states that 
the absorption of C-N bond vibrations was in 
the wavenumber 1340-1250 cm
-1
 (Coates, 
2000). The C-Cl stretching vibration 
absorption is theoretically in the region of the 
wavenumber 800-700 cm
-1
 (Coates, 2000). 
Based on the analysis results of C-Cl vibration 
absorption of complex compounds found in the 
region of 746.45 cm
-1
. Based on the literature, 
the vibration absorption of the O group from 
ligands with metals would appear at 
wavenumbers 600-400 cm
-1
. The results of the 
analysis of Fe-O vibration absorption from 
ligands N'-(4-Chlorobenzoyl)isonicotino 
hydrazide appeared in the region of 530.42 cm
-
1
 (Nakamoto, 1978; Setyawati, 2010). A shift 
in the wavenumber of the Fe-O bond indicated 
that the complex compound synthesized has 
formed. Predictions of bonds that occured 























The docking process was performed 
using AutodockTools-1.5.6 software between 
Fe (III) N'-(4-Chlorobenzoyl)isonicotinohy-
drazide with enzyme target (PDB code 2X23) 
through several stages. 




The Ligand and Receptors Preparation 
Ligand preparation was performed 
using Marvin Sketch 5.2 software. Then 
geometry optimization was done by 
protonation at pH 7.4. This aims to adjust the 
pH condition of blood in the human body 
because the docking process mimics the 
reactions that occur in the body. Whereas the 
enzyme preparation was performed using the 
AutodockTools-1.5.6 software to remove 
water and add hydrogen atoms (Agistia, 2013; 
Rachmania, 2018). 
The Validation  of Docking Method  
The parameter used for this validation 
was RMSD (Root Mean Square Deviation). 
The docking method was said to be valid if 
the RMSD value ≤ 2. The smaller the RMSD 
value indicates that the predicted ligand pose 
was getting better because it approached the 
native conformation (Hawkins, 2008; Agistia, 
2013). The results of docking validation could 
be seen in Table 5. 
 




Grid Box RMSD 
(Å) 
Binding Affinity 
(kcal/mol) X y z 
2X23 -19.024 -5.263 -29.471 1.52 -4.86  
 
 
Based on Table 5, the RMSD value for 
GDP code 2X23 was 1.52, the value was  < 2 





Figure 4.  The overlay between native ligand 
(green)  and re-docking  (yellow) 
 
Analysis of Enzyme Target  
Enzyme target analysis was performed 
on validated receptors or proteins in the 
docking validation process. Analysis of the 
target receptor or protein aimed to determine 
the status of the 3D structure of a protein from 
X-ray crystallography or NMR, through the 
Ramachandran plot.  The enzyme structure 
was stated to be good if the number of residual 
plots in most favored regions was more than 
50% and in disallowed regions was less than 
15% (Ruswanto et al., 2018; Amelia, 2013). 
Based on observations (Figure 5 and 
Table 6) receptor or target protein (PDB code 
2X23) has a good protein structure because the 
residual plots in most favored regions are more 
than 50%, namely 92.1% and in disallowed 
regions less than 15%, which is 1%. 
 
The Docking of Complex compound 
 
 
Figure 5. The Ramachandran plot of enzyme target 
(code PDB 2X23) 
 
The next step was docking the 
compound Fe (III) N'-(4-Chlorobenzoyl) 
isonicotinohydrazide, and the comparison 
compound was N'-(4-Chlorobenzoyl) 
isonicotinohydrazide against enzyme with the 
code PDB 2X23. The docking results were 
shown in Table 6.  
 





Table 6. Ramachandran plot statistics 
 
Parameters No. of Residues %-tage 
Most favoured regions      [A,B,L] 
Additional allowed regions [a,b,l,p] 
Generously allowed regions [~a,~b,~l,~p] 









Non-glycine and non-proline residues 900 100% 
End-residues (excl. Gly and Pro)  






Total number of residues 1072  
 
Table 7. The docking results 
 




Native ligand -4.86 273.25 
N’-(4-Chlorobenzoyl)isonicotinohydrazide -6.35 22.11 
Fe(III)(N’-(4-Chlorobenzoyl))isonicotinohydrazide -9.80 0.06529 
 
 
Based on the docking results (Table 7) 
obtained for Mycobacterium tuberculosis, the 
value of Gibbs (ΔG) / binding affinity (-9.80 
kcal/mol) and inhibition constant values 
(0.06529 μM) of the complex compound Fe 
(III) N'-(4-Chlorobenzoyl)isonicotinohydra-
zide was lower than the comparative 
compounds. So it could be said that the 
complex compound Fe (III) N'-(4-Chloro 
benzoyl)isonicotinohydra-zide has a better and 
more stable interaction compared to the 
comparison compound. 
 
Visualization of Docking Results 
The docking results were visualized to 
find out the interaction between the ligand and 
the amino acid residues of the enzyme. 
Enzyme-ligand interactions could be seen in 
Table 7. Based on Table 7, it could be seen 
that the interaction of the complex Fe (III) N '- 
(4-Chlorobenzoyl) isonicotinohydrazide with 
amino acid residues through hydrophobic 
bonds and hydrogen bonds. Hydrophobic 
bonds in complex compounds interact with 20 
amino acids namely Gly96, Ser94, Ser123, 
Met98, Met103, Ile202, Val203, Met232, 
Ile194, Leu218, Thr196, Ile21, Met147, 
Asp148, Gly14, Ser20, Ile95, Ile202, Val203, 
Met232, Ile194, Leu218, Thr196, Ile21, 
Met147, Asp148, Gly14, Ser20, Ile95, Lys165, 
Gly192 and Ph97 . Hydrogen bonds in 
complex compounds interact with only one 
amino acid, Tyr158. 
ADME and toxicity tests were carried 
out to determine the pharmacokinetic profile 
to see the safety of complex compounds. The 
absorption parameters were predicted based 
on the ability of the drug absorbed in the 
intestine (Human Intestinal Absorption) and 
the ability of permeability in Caco-2 cells. 
Distribution parameters are predicted based on 
the attachment to plasma proteins. While the 
toxicity parameters can be seen from the 
Ames test. The results of ADME predictions 
and toxicity can be seen in Table 8. 
Based on ADME predictions (Table 
8) isoniazid, compounds before the N'-(4-
Chlorobenzoyl) isonicotinohydrazide complex 
and Fe (III) N' - (4-Chlorobenzoyl) isonico-
tinohydrazide complex each had an HIA value 
of 87,106%, 93,058% and 93,058%, 
respectively. 100% The HIA value of all 
compounds were in the range of 70-100% 
which indicated that the compounds could be 
absorbed well, but it could be seen the 
acquisition of HIA values of complex 
compounds was greater than the compound 
before the complex and its free ligand 
(isoniazid), which means that the compound-
complex could be said to have better 
absorption than the other compounds. 
From Table 8, it could be seen that the 
Caco-2 value of isoniazid, the compound 
before the complex or complex compound was 
in the range of 4-70 nm/sec which indicated 
that the permeability of all compounds was 
moderate.




Table 7. The interaction between compound with amino acid residue on enzyme target 
 
Compound Hydrophobic Bonds Hydrogen Bond 
Native ligand 
Asp158, Met47, Gln214, Ile215, Met155, Tyr158, 




Pro156, Met147, Asp148, Ala191,Gly192, Pro193, 




Gly96, Ser94, Ser123, Met98, Met103,Ile202, Val203, 
Met232, Ile194, Leu218, Thr196, Ile21, Met147, 





                                                   
                                            (a)                                                                (b) 
                                                    
Figure 6. (a) 2D visualization (b) 3D visualization of complex compound 
  
 
The ADME and Toxicity Prediction 
Table 8. The ADME and toxicity prediction results 
 
Compound       Absorption  Distribution Toxicity 
 HIA 
(%) 
CaCo-2 (nm/sec) PPB (%) (Ames test) 
Isoniazid 87.106 19.496 1.607 Mutagen 




















Classification: HIA(%) 0-20= Poorly absorbed compounds, 20-70= Moderately absorbed compounds, 70-100= Well absorbed compounds; 
Caco-2(nm/sec) <4= Low permeability, 4-70= Middle permeability, >70= High permeability; PPB(%) >90= Chemicals strongly bound, 
<90= Chemicals weakly bound (Nursamsiar, 2016). 
 
 
The efficacy of a drug was influenced 
by the binding of plasma proteins, which were 
generally only drugs in an unbound form that 
could diffuse through the cell membrane and 
interact with the receptors. (Nursamsiar, 
2016). In Table 8, the complex compounds 
and their comparative compounds have a 
weak attachment to plasma proteins, because 





the value of plasma protein binding (PPB) of 
all compounds <90% so that it could be said 
that the all compounds could be well 
distributed. But the PPB value of complex 
compounds was lower (52.159%) than the 
compound before the complex so that it can 
be said that the distribution of complex 
compounds was better than the compounds 
before the complex 
The toxicity parameters could be seen 
from the mutagenic properties of the 
compounds being tested. Mutagen was a 
compound that could increase the rate of 
change or mutation in genes so that it could 
trigger the development of cancer 
(Wahyuningrum, 2011). From the prediction 
of toxicity using the PreADMET program 
showed that both complex and comparison 
compounds have mutagen properties. 
Although mutagenic, this compound could 
still be applied as a candidate drug with the 
appropriate dosage (Ruswanto et al., 2018). 
 
4. CONCLUSION 
Based on the research, it can be 
concluded that the complex FeIII) (N' (4-
Chlorobenzoyl) isonicotinohydrazide can be 
synthesized through the reaction between 
FeCl3.6H2O and N' - (4-Chlorobenzoyl) 
isonicotinohydrazide. 
The results of molecular docking 
showed that the complex Fe(III) N'-(4-
Chlorobenzoyl) isonicotinohydrazide could 
interact with the enzyme Enoyl-Acyl Carrier 
Protein Reductase on Mycobacterium 
tuberculosis and were predicted to have a 
better interaction than isoniazid or N'-(4-
Chlorobenzoyl) isonicotinohydrazide with the 
acquisition of free energy binding (ΔG) value 
of -9.80 kcal/mol and inhibition constant (Ki) 
of 0.06529 μM. 
For further studies, molecular 
dynamics must observe the stability of 




Thank to the Ministry of Research, 
Technology and Higher Education for PDUPT 
Grant in 2018 and to STIKes BTH for all 




Agistia DD, Purnomo H, Tegar M, Nugroho AE. 
2013. Interaction between active 
compounds from aegle marmelos correa as 
anti inflammation agent with COX-1 and 
COX-2 receptor. Traditional Medicine 
Journal. 18(2): 80–87. 
 
Ali M, Ahmed M, Hafiz S, Kamal M, Mumtaz M, 
Hanif M, Khan KM. 2017. Metal 
complexes of isonicotinylhydrazide and 
their antitubercular activity. Pak. J. 
Pharm. Sci. 30(7): 2399–2403. 
 
Amelia F. 2013. Modeling struktur protein vaksin 
H5N1 HA BTB menggunakan I-Tasser. 
Sainstek. 7(1): 1-5. 
 
Borde V, Naglolkar B, Shankarwar S, Shankarwar 
A. 2015. Synthesis and characterization of 
antimicrobial activities of some transition 
metal complexes of asymmetrical 
tetradentate ligands. Research Journal of 
Chemical Sciences. 5(5): 19–23. 
 
Coates J. 2000. Interpretation of Infrared Spectra, A 
Practical Approach. Encyclopedia of 
Analytical Chemistry: 1–23. 
 
Dharmayanti A, Martak F. 2015. Sintesis senyawa 
aktif kompleks mangan(II) dengan ligan 
2(4-nitrofenil)-4,5-difenil-1H-imidazol. 
Jurnal Sains Dan Seni ITS. 4(2): 52–56. 
 
Endah SRN, Mardianingrum R, Ruswanto. 2018. 
Identifiksi target reseptor senyawa 10,11-
dihidroerisodin sebagai kandidat 
antikanker secara in silico. Jounal of 




Goeswin A. 2012. Sediaan Farmasi Padat. 
Bandung: ITB. 
 
Hastuti IW, Brams DW. 2017. Karakterisasi butiran 
sub mikron nanomaterial karbon batok 
kelapa dengan variasi waktu pengadukan 
bahan yang digunakan untuk filtrasi logam 
Fe dari limbah air selokan mataram 
berdasarkan uji Uv-Vis, XRD, SEM dan 
AAS. Jurnal Fisika. 6(4): 308–318. 
 
Hawkins PCD, Warren GL, Skillman AG, Nicholls 
A. 2008. How to do an evaluation : pitfalls 




Kemenkes RI. (2016). Peraturan Menteri 
Kesehatan Republik Indonesia No. 67 
tentang Penanggulangan Tuberkulosis. 




Jakarta: Kememterian Kesehatan Republik 
Indonesia. 
 
Kusyanto A, Sugiyarto KH. 2017. Sintesis dan 
karakterisasi senyawa kompleks besi (III) 
dengan ligan 1,10-fenantrolin dan anion 
trifluorometanasulfonat. Jurnal Kimia 
Dasar. 6(1): 51–58. 
 
Mallikarjuna NM, Keshavayya J, Ravi BN. 2018. 
Synthesis, spectroscopic characterization, 
antimicrobial, antitubercular and DNA 
cleavage studies of 2-(1H-indol-3-
yldiazenyl)-4,5,6,7-tetrahydro-1,3-
benzothiazole and its metal complexes. 
Journal of Molecular Structure. 1173: 
557–566.  
 
Mardianingrum R, Susanti, Ruswanto R. 2020. 
Bis(N′-(3-Clorobenzoyl)isonicotinohydra-
zide)iron(III) Complex. Molbank. 
2020(1).  M1101. 
 
Mardianingrum R, Ruswanto R, Nurjanah R, 
Nofianti T, Apriliani AY. 2019. The 
biology activities of isonicotinohydrazide 
derivatives as an anti-tuberculosiss 
candidate the biology activities of 
isonicotinohydrazide derivatives as an 
anti-tuberculosis candidate, IOP Conf. 
Series: Journal of Physics: Conf. Series. 
1179(2019): 012181. 
 
Ming XL, Jing Z, Zi LW, Jing PW. 2008. 
Synthesis, crystal structure and antitumor 
study of a cobalt (II) complex of the 2-
acetylpyrazine thiosemicarbazone. Z. 
Naturforsch. 63b: 1-5. 
 
Nakamoto. 1978. Infrared and Raman Spectra of 
Inorganic and Coordination Compound 
(Third Edition). New York: John Wiley 
and Sons, Inc. 
 
Ningtyas AP, Martak F. 2016. Sintesis dan uji 
toksisitas kompleks kobalt(II) dengan 
ligan (6E)-(N2)-((E)-2-(6-aminopiridin- 2-
ilimino)-1,2-difeniletilidin)piridin-2,6- 
diamina. Jurnal Sains Dan Seni ITS. 5(2): 
3–7. 
 
Nursamsiar, Toding AT, Awaluddin A. 2016. Studi 
in silico senyawa turunan analog kalkon 
dan pirimidin sebagai antiinflamasi: 
prediksi absorpsi, distribusi dan toksisitas. 
Pharmacy. 13(1): 92–100. 
 
Pal S, Kumar V, Kundu B, Bhattacharya D, Preethy 
N, Reddy MP, Talukdar A. 2019. Ligand-
based pharmacophore modeling, virtual 
screening and molecular docking studies 
for discovery of potential topoisomerase I 
inhibitor. Computational and Structural 




Rachmania RA, Haeyanti, Zikriah R, Sultan A. 
2018. Studi in silico senyawa alkaloid 
herba bakung putih (Crinum Asiaticum L.) 
pada penghambatan enzim siklooksigenase 
(COX). Jurnal Kimia Valensi. 4(2): 124–
136. 
 
Ritmaleni, Nurcahyani W. 2006. Sintesis 4-fenil-
3,4-tetrahidro-indeno [2,1]-pirimidin-2-on 
(LR-l). Majalah Farmasi Indonesia. 17(3): 
149–155. 
 
Ruswanto R, Sarwatiningsih Y, Pratita ATK, Indra, 
Dewi R. 2019. Synthesis and 
characterization of Fe ( III ) complex with 
N’-(3-Nitrobenzoyl) isonicotinohydrazide 
as an anti-tuberculosis candidate. IOP 
Conf. Series: Journal of Physics: Conf. 
Series. 1179(2019): 012136. 
 
Ruswanto R, Mardianingrum R, Lestari T, Nofianti 
T, Rahayuningsih N. 2019. Synthesis and 
molecular docking of isonicotinohydrazide 
derivatives as anti-tuberculosis candidates. 
Malaysian Journal of Fundamental and 
Applied Sciences. 15(3): 367-371. 
 
Ruswanto, Wulandari WT, Rahayu S, 
Mardianingrum R, Hidayati ND. 2020. 
Studi in silico dan bioaktivitas senyawa 
turunan N’-benzoylisonicotinohydrazide 
(4-methyl, 4-cloro dan 3,5-dinitro) pada 
Mycobacterium tuberculosis (H37Rv), 
bakteri gram positif serta bakteri gram 
negatif. Pharmacoscript. 2(2): 118-130. 
 
Ruswanto R, Mardianingrum R, Apriliani AY, 
Ramadaniah FK, Sarwatiningsih Y, Pratita 
ATK, Nuryani GS, Rahayuningsih N, 
Lindaswastuti L, Rahayu SS, Wulandari 
WT, Lihandini G. 2018. Karakterisasi dan 
sintesis senyawa kompleks Fe (III) sebagai 
kandidat anti tuberkulosis. Journal of 
Pharmacopolium. 1(2): 100–106. 
 
Ruswanto R, Garna IM, Tuslinah L, 
Mardianingrum R, Lestari T, Nofianti T. 
2018. Kuersetin: penghambat uridin 5-
monofosfat sintase sebagai kandidat 
antikanker. ALCHEMY Jurnal Penelitian. 
14(2): 236–252. https://doi.org/10.20961/ 
alchemy.14.2.14396.236-254.  
 





Setyawati H, Murwani IK. 2010. Sintesis dan 
Karakterisasi Senyawa Kompleks 
Besi(III)-EDTA. Prosiding Seminar 
Nasional Sains. 
 
Siswandono, Soekarjdo B. 2016. Kimia Medisinal 
Edisi 2. Surabaya: Airlangga University 
Press. 
 
Sousa EHS, Basso LA, Santos DS, Diógenes ICN, 
Longhinotti E, de França Lopes LG, de 
Sousa Moreira Í. 2011. Isoniazid metal 
complex reactivity and insights for a novel 
anti-tuberculosis drug design. JBIC 
Journal of Biological Inorganic 
Chemistry. 17(2): 275–283. doi:10.1007/ 
s00775-011-0848-x  
 
Suo J, Chang CE, Lin TP, Heifets LB. 1988. 
Minimal inhibitory concentrations of 
isoniazid, rifampin, ethambutol, and 
streptomycin against Mycobacterium 
tuberculosis strains isolated before 
treatment of patients in Taiwan. American 
Review of Respiratory Disease. 138(4): 
999–1001. doi:10.1164/ajrccm/138.4.999 . 
 
Tarallo MB, Urquiola C, Monge A, Costa BP, 
Ribeiro RR, Filho AJC, Mercader RC, 
Pavan FR, Leite CQF, Torre MH, 
Gambino D. 2010. Design of novel iron 
compounds as potential therapeutic agents 
against tuberculosis. Journal of Inorganic 
Biochemistry. Elsevier Inc. 104(11): 
1164–1170. doi: 10.1016/j.jinorgbio.2010. 
07.005. 
 
Wahyuningrum R, Wirasutisna KR, Elfahmi, 
Wibowo MS. 2011. Efek mutagenik 
ekstrak metanol ampas biji jarak (Jatropha 
curcas L.) sisa pengolahan bahan bakar 
nabati (biofuel). Majalah Obat 
Tradisional. 15(3): 89–93. 
 
WHO. 2018. Global Tuberculosis Report 2018. 
Geneva. 
 
 
